Basit öğe kaydını göster

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

dc.contributor.authorTzekova, V
dc.contributor.authorRamlau, R
dc.contributor.authorJassem, J
dc.contributor.authorGrgic, M
dc.contributor.authorPinar, S
dc.contributor.authorSzilasi, M
dc.contributor.authorWiltschke, C
dc.contributor.authorWagnerova, M
dc.contributor.authorOskina, N
dc.contributor.authorSoldatenkova, V
dc.contributor.authorZielinski, C
dc.contributor.authorWenczl, M
dc.contributor.authorBrodowicz, T
dc.contributor.authorKrzakowski, M
dc.contributor.authorZwitter, M
dc.contributor.authorGhilezan, N
dc.contributor.authorCiuleanuf, T
dc.contributor.authorCucevic, B
dc.contributor.authorGyurkovits, K
dc.contributor.authorUlsperger, E
dc.date.accessioned2021-03-06T09:34:49Z
dc.date.available2021-03-06T09:34:49Z
dc.date.issued2006
dc.identifier.citationBrodowicz T., Krzakowski M., Zwitter M., Tzekova V., Ramlau R., Ghilezan N., Ciuleanuf T., Cucevic B., Gyurkovits K., Ulsperger E., et al., "Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial", LUNG CANCER, cilt.52, ss.155-163, 2006
dc.identifier.issn0169-5002
dc.identifier.otherav_e6352f99-a2d0-46b2-8621-cc6ad1fd3f8e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/151440
dc.identifier.urihttps://doi.org/10.1016/j.lungcan.2006.01.006
dc.description.abstractPurpose: The primary objective of this randomized phase III study was to show significant difference in median time to progression (TTP) in patients with advanced NSCLC treated with single-agent gemcitabine maintenance therapy versus best supportive care following gemcitabine plus cisplatin initial first-line therapy.
dc.language.isoeng
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSOLUNUM SİSTEMİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.titleCisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial
dc.typeMakale
dc.relation.journalLUNG CANCER
dc.contributor.department, ,
dc.identifier.volume52
dc.identifier.issue2
dc.identifier.startpage155
dc.identifier.endpage163
dc.contributor.firstauthorID178667


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster